[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574360":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":34,"collaborators":10,"id":36,"slug":10,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":10,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":10,"maxAge":10,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":10,"briefSummary":48,"conditions":49,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"Kissei Pharmaceutical Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Avacopan treatmented",null,[12],"Drug: Avacopan",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","Avacopan","oral administration",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Kazunori Abe, director","CONTACT","0356843575","rinsyousiken@pharm.kissei.co.jp",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":10,"geoPoint":10,"contacts":32},"Research site","RECRUITING","Multiple Locations","Japan","JP",[33],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100574360",false,"NCT06758271","Special Drug Use-results Survey for Long-term Use（Avacopan）","Special Drug Use-results Survey for Long-term Use","Inclusion Criteria:\n\n* Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan","ALL",{"count":44,"type":45},250,"ESTIMATED","2 Years","OBSERVATIONAL","The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.",[50,51],"Microscopic Polyangiitis (MPA)","Granulomatosis With Polyangiitis (GPA)","2025-01-15",{"date":54,"type":55},"2025-01-17","ACTUAL",{"date":57,"type":55},"2022-07-29",{"date":59,"type":45},"2028-05-31",{"name":5,"class":6},1]